Elevated ATGL in colon cancer cells and cancer stem cells promotes metabolic and tumorigenic reprogramming reinforced by obesity

Elevated ATGL in colon cancer cells and cancer stem cells promotes metabolic and tumorigenic reprogramming reinforced by obesity

Abstract Obesity is a worldwide epidemic associated with increased risk and progression of colon cancer. Here, we aimed to determine the role of adipose triglyceride lipase (ATGL), responsible for intracellular lipid droplet (LD) utilization, in obesity-driven colonic tumorigenesis. In local colon c...

Full description

Bibliographic Details
Main Authors:	Rida Iftikhar, Harrison M. Penrose, Angelle N. King, Joshua S. Samudre, Morgan E. Collins, Alifiani B. Hartono, Sean B. Lee, Frank Lau, Melody Baddoo, Erik F. Flemington, Susan E. Crawford, Suzana D. Savkovic
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-11-01
Series:	Oncogenesis
Online Access:	https://doi.org/10.1038/s41389-021-00373-4

Similar Items

Correction: Elevated ATGL in colon cancer cells and cancer stem cells promotes metabolic and tumorigenic reprogramming reinforced by obesity
by: Rida Iftikhar, et al.
Published: (2022-03-01)

Loss of Forkhead Box O3 Facilitates Inflammatory Colon Cancer: Transcriptome Profiling of the Immune Landscape and Novel TargetsSummary
by: Harrison M. Penrose, et al.
Published: (2019-01-01)

Transcriptomic analysis identifies B-lymphocyte kinase as a therapeutic target for desmoplastic small round cell tumor cancer stem cell-like cells
by: Justin W. Magrath, et al.
Published: (2024-01-01)

Bacterial TLR4 and NOD2 signaling linked to reduced mitochondrial energy function in active inflammatory bowel disease
by: Emmanuelle Ruiz, et al.
Published: (2020-05-01)

Recent Advances on the Role of ATGL in Cancer
by: Renshuai Zhang, et al.
Published: (2022-07-01)

3253 Identification of Immune Cell Profiles and Molecular Pathways in Inflammatory Bowel Disease Driving Non-Response to Biologic Therapy
by: Harrison Michael Penrose, et al.
Published: (2019-03-01)

Epiploic Adipose Tissue (EPAT) in Obese Individuals Promotes Colonic Tumorigenesis: A Novel Model for EPAT-Dependent Colorectal Cancer Progression
by: Rida Iftikhar, et al.
Published: (2023-02-01)

Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy
by: Harrison M. Penrose, et al.
Published: (2021-04-01)

FOXO3 Expression in Macrophages Is Lowered by a High-Fat Diet and Regulates Colonic Inflammation and Tumorigenesis
by: Rida Iftikhar, et al.
Published: (2022-03-01)

UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma
by: Yanchen Wang, et al.
Published: (2023-06-01)

“Pulsed Hypoxia” Gradually Reprograms Breast Cancer Fibroblasts into Pro-Tumorigenic Cells via Mesenchymal–Epithelial Transition
by: Anna Nushtaeva, et al.
Published: (2023-01-01)

FOXO3 Deficiency in Neutrophils Drives Colonic Inflammation and Tumorigenesis
by: Jenisha Ghimire, et al.
Published: (2023-06-01)

LINE-1 promotes tumorigenicity and exacerbates tumor progression via stimulating metabolism reprogramming in non-small cell lung cancer
by: Zeguo Sun, et al.
Published: (2022-07-01)

ATGL and DGAT1 are involved in the turnover of newly synthesized triacylglycerols in hepatic stellate cells[S]
by: Maidina Tuohetahuntila, et al.
Published: (2016-07-01)

Reversal of splicing infidelity is a pre-activation step in B cell differentiation
by: Tina M. O’Grady, et al.
Published: (2022-12-01)

Cancer Stem Cell-Exosomes, Unexposed Player in Tumorigenicity
by: Batla S. Al-Sowayan, et al.
Published: (2020-03-01)

Abstract QS51: Skeletal Muscle Regeneration by Fibromodulin Reprogrammed Cells without Tumorigenic Risks
by: Pin Ha, MD, DDS, MS, et al.
Published: (2018-04-01)

BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells
by: Teresa Rossi, et al.
Published: (2023-01-01)

Generation of Stable Epithelial–Mesenchymal Hybrid Cancer Cells with Tumorigenic Potential
by: Roslyn Tedja, et al.
Published: (2023-01-01)

Cell-in-cell phenomenon: leukocyte engulfment by non-tumorigenic cells and cancer cell lines
by: Mareike F. Bauer, et al.
Published: (2021-07-01)

Cytokine-Mediated STAT3 Transcription Supports ATGL/CGI-58-Dependent Adipocyte Lipolysis in Cancer Cachexia
by: Aakash Y. Gandhi, et al.
Published: (2022-06-01)

Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity
by: Claudia Koch, et al.
Published: (2020-09-01)

Selective targeting of tumorigenic cancer cell lines by microtubule inhibitors.
by: Newaj M Abdullah, et al.
Published: (2009-01-01)

Interleukin-34 promotes tumorigenic signals for colon cancer cells
by: Eleonora Franzè, et al.
Published: (2021-09-01)

FPR1 mediates the tumorigenicity of human cervical cancer cells
by: Cao G, et al.
Published: (2018-11-01)

NLRP6, decreased in gastric cancer, suppresses tumorigenicity of gastric cancer cells
by: Wang Q, et al.
Published: (2018-11-01)

Tumor Microenvironment Uses a Reversible Reprogramming of Mesenchymal Stromal Cells to Mediate Pro-tumorigenic Effects
by: Armel H. Nwabo Kamdje, et al.
Published: (2020-11-01)

Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells
by: Lucie M. Frerichs, et al.
Published: (2023-09-01)

The crucial role of ATGL for energy supply of muscles1
by: Gunilla Olivecrona
Published: (2010-03-01)

Rapamycin response in tumorigenic and non-tumorigenic hepatic cell lines.
by: Rosa H Jimenez, et al.
Published: (2009-10-01)

Reprogramming Synthetic Cells for Targeted Cancer Therapy
by: Lim, B, et al.
Published: (2022)

Induction of differentiation inhibits the tumorigenic potential of glioblastoma cancer stem cells
by: F. M. Brehar, et al.
Published: (2011-12-01)

Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells.
by: Rebecca A Rowehl, et al.
Published: (2014-01-01)

Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like properties.
by: Benoit Lacoste, et al.
Published: (2017-01-01)

RNA Profile of Cell Bodies and Exosomes Released by Tumorigenic and Non-Tumorigenic Thyroid Cells
by: Valentina Maggisano, et al.
Published: (2024-01-01)

Galactosylceramide affects tumorigenic and metastatic properties of breast cancer cells as an anti-apoptotic molecule.
by: Tomasz B Owczarek, et al.
Published: (2013-01-01)

Senescence-Induced Alterations of Laminin Chain Expression Modulate Tumorigenicity of Prostate Cancer Cells
by: Cynthia C.T. Sprenger, et al.
Published: (2008-12-01)

SERPINB2 Is a Novel Indicator of Cancer Stem Cell Tumorigenicity in Multiple Cancer Types
by: Na-Hee Lee, et al.
Published: (2019-04-01)

Editorial: Reprogramming Stromal Cells in Chronic Inflammation and Cancer
by: Ana Igea, et al.
Published: (2021-11-01)

β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells.
by: Jinhua Xu, et al.
Published: (2015-01-01)